Janux Therapeutics Inc (JANX)
54.19
-0.98
(-1.78%)
USD |
NASDAQ |
Dec 27, 10:28
Janux Therapeutics Research and Development Expense (Quarterly): 18.61M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Rezolute Inc | 12.75M |
| Vir Biotechnology Inc | 195.18M |
| Cytokinetics Inc | -- |
| Galectin Therapeutics Inc | 7.595M |
| Spero Therapeutics Inc | 26.86M |